Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$415M |
| 2 |
Eli Lilly
LLY
|
+$402M |
| 3 |
Goldman Sachs
GS
|
+$384M |
| 4 |
McDonald's
MCD
|
+$379M |
| 5 |
Tesla
TSLA
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.98B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 3 |
AT&T
T
|
+$460M |
| 4 |
Synchrony
SYF
|
+$398M |
| 5 |
Honeywell
HON
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.53% |
| 2 | Financials | 4.78% |
| 3 | Healthcare | 3.89% |
| 4 | Industrials | 3.6% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
4726
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.52M | ﹤0.01% |
88,303
+31,894
| +57% | +$505K |
|
|
NVTA
4727
CALL
DELISTED
Invitae Corporation
NVTA
| $1.52M | ﹤0.01% |
64,900
+19,400
| +43% | +$342K |
|
4728
Direxion Daily Small Cap Bear 3x ETF
TZA
$202M
| $1.52M | ﹤0.01% |
385
-725
| -65% | -$3.11M |
|
4729
Vipshop
VIPS
$7.53B
| $1.52M | ﹤0.01% |
189,015
-636,244
| -77% | -$4.51M |
|
4730
CALL
Flowserve
FLS
$10.2B
| $1.51M | ﹤0.01% |
33,500
+6,500
| +24% | +$284K |
|
|
HSKA
4731
DELISTED
Heska Corp
HSKA
| $1.51M | ﹤0.01% |
17,753
-4,084
| -19% | -$368K |
|
4732
CALL
BCE
BCE
$21.2B
| $1.51M | ﹤0.01% |
34,000
+5,100
| +18% | +$220K |
|
4733
Renasant Corp
RNST
$3.91B
| $1.51M | ﹤0.01% |
44,603
-11,359
| -20% | -$405K |
|
4734
PUT
Banco Santander
SAN
$210B
| $1.51M | ﹤0.01% |
339,861
+174,783
| +106% | +$797K |
|
4735
CALL
RenaissanceRe
RNR
$13.4B
| $1.51M | ﹤0.01% |
10,500
-2,100
| -17% | -$294K |
|
|
TUP
4736
CALL
DELISTED
Tupperware Brands Corporation
TUP
| $1.51M | ﹤0.01% |
58,900
-14,600
| -20% | -$446K |
|
4737
Berkshire Hathaway Class A
BRK.A
$1.12T
| $1.51M | ﹤0.01% |
+5
| New | +$1.51M |
|
|
NVRO
4738
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.51M | ﹤0.01% |
24,100
-200
| -0.8% | -$9.4K |
|
|
AIMT
4739
CALL
DELISTED
Aimmune Therapeutics
AIMT
| $1.51M | ﹤0.01% |
67,400
+9,900
| +17% | +$233K |
|
4740
PUT
Medifast
MED
$141M
| $1.5M | ﹤0.01% |
11,800
-5,000
| -30% | -$634K |
|
4741
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
| $1.5M | ﹤0.01% |
10,400
-13,200
| -56% | -$1.84M |
|
4742
Intellia Therapeutics
NTLA
$1.67B
| $1.5M | ﹤0.01% |
88,104
+62,159
| +240% | +$927K |
|
4743
Univest Financial
UVSP
$1.18B
| $1.5M | ﹤0.01% |
61,480
-19,898
| -24% | -$486K |
|
|
HDS
4744
PUT
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.5M | ﹤0.01% |
34,600
+7,400
| +27% | +$308K |
|
4745
CALL
Fossil Group
FOSL
$318M
| $1.5M | ﹤0.01% |
109,100
-168,200
| -61% | -$2.68M |
|
4746
CALL
Rayonier Advanced Materials
RYAM
$610M
| $1.5M | ﹤0.01% |
110,400
+85,200
| +338% | +$1.15M |
|
4747
Vanguard Total World Bond ETF
BNDW
$1.89B
| $1.49M | ﹤0.01% |
+19,435
| New | +$1.47M |
|
4748
CALL
EPR Properties
EPR
$4.77B
| $1.49M | ﹤0.01% |
19,400
-3,300
| -15% | -$240K |
|
|
ODP
4749
DELISTED
ODP
ODP
| $1.49M | ﹤0.01% |
41,101
-64,859
| -61% | -$2.08M |
|
|
AMED
4750
CALL
DELISTED
Amedisys
AMED
| $1.49M | ﹤0.01% |
12,100
-13,200
| -52% | -$1.66M |
|
Similar funds
Citadel Advisors's Q1 2019 Portfolio in Review
As of Q1 2019, Citadel Advisors held 10,449 positions worth $201B, up 10% from $183B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors withdrew a net $13B in Q1 2019, closing 1,252 positions and reducing 3,810 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $223M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.5% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Citadel Advisors opened a new position in Elanco Animal Health worth $251M.
- Citadel Advisors's largest Q1 2019 buy was Elanco Animal Health: 7,832,197 shares worth $251M.
- Citadel Advisors added most to Walt Disney in Q1 2019, an estimated $415M increase.
- Citadel Advisors's biggest Q1 2019 reduction was Amazon, cutting an estimated $1.98B.
- Citadel Advisors fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $223M.
- Citadel Advisors's ten largest holdings make up 24% of its $201B portfolio in Q1 2019.
- Citadel Advisors opened 1,429 new positions and closed 1,252 in Q1 2019.
- Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $201B.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.